MedTrace Logo

AmbuLatory Pediatric Asthma CAre

NCT05517096 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-11-06

No results posted yet for this study

Summary

The ALPACA study has a prospective randomized control interventional design, including a follow-up period to evaluate follow-up effects. The study is divided into two phases of 3 months using eHealth and observational monitoring.

Conditions

  • Asthma in Children

Interventions

OTHER

E-Health

In the intervention phase asthma care is provided on an at-needed-basis via online communication and is always available during working hours.

Sponsors & Collaborators

  • Medisch Spectrum Twente

    collaborator OTHER

  • Philips Electronics Nederland B.V. acting through Philips CTO organization

    lead INDUSTRY

Principal Investigators

  • B.J. Thio, Pediatrician · Medisch Spectrum Twente

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-07
Primary Completion
2023-09-15
Completion
2024-03-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05517096 on ClinicalTrials.gov